Bayer unit tagged with $289 million Roundup cancer verdict
Bayer subsidiary Monsanto faces a $289 million jury verdict over its weedkiller Roundup, which has been linked to cancer.
A jury in California found in favor of a retired school groundskeeper who used Roundup as a pesticide for decades. The dying man discovered tumors all over his body, and was diagnosed with in cancer in 2014. Doctors told him last year that he had six months to live.
The MDL proceeding for Roundup cases is called MDL 2741
Roundup is made and sold by Monsanto, which is part of German pharmaceutical giant Bayer. Some of the people who trusted Roundup for years are now sick with a type of cancer called non-Hodgkin lymphoma. Others have multiple myeloma, leukemia and other kinds of cancer
Glyphosate linked to injuries
The main ingredient in Roundup, glyphosate, is the subject of scrutiny by government agencies and non-profit research groups that say glyphosate is hazardous to human health. Hundreds of lawsuits accuse Monsanto of hiding the risks of Roundup, and failing to warn about the risk of cancer. Glyphosate was approved for use in Roundup in 1974